Insights Into Cockayne Syndrome Type B: What Underlies Its Pathogenesis?
Aging Cell · 2025
DOI: 10.1111/acel.70136 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging Cell, 2025. Verfasst von Ricardo Afonso-Reis und 3 weiteren Autor:innen. Beteiligte Einrichtung: ABC-RI, Algarve Biomedical Center Research Institute, Faro, Portugal. Hauptthemen laut MEDLINE: Cockayne Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cockayne Syndrome (CS) is an autosomal recessive disorder arising from mutations in either of two disease‐associated genes, ERCC6 or ERCC8 . CS patients exhibit cutaneous photosensitivity, neuropathological abnormalities, severe growth retardation, a distinctive facial appearance with pronounced sunken eyes, musculoskeletal anomalies, sensory impairment, and dental decay. Approximately 70% of all CS cases carry ERCC6 mutations; therefore, this review will focus solely on Cockayne Syndrome complementation group B (CS‐B). CS‐B exhibits several hallmarks of aging, including genomic instability, epigenetic modifications, loss of proteostasis, and mitochondrial failure. CS‐B is proposed to result from the accumulation of DNA damage and the resulting transcription impairment. However, the main pathophysiological mechanisms underlying the severe cellular impairments observed in CS‐B remain unclear. Here, we review the current literature to elucidate ERCC6‐related mechanisms, highlighting the key and emerging pathological mechanisms underlying CS‐B, as well as their putative interactions. Considering the mechanisms that heavily rely on ERCC6, we propose that CS‐B pathogenesis arises from a combination of DNA damage accumulation, transcriptional dysregulation, and mitochondrial dysfunction. Furthermore, we argue that these molecular features influence each other, rather than acting as isolated mechanisms. This suggests that the crosstalk between mechanisms is a key factor for CS‐B pathogenesis. Although efforts have been made to unveil CS‐B pathogenesis, research is still lacking, hindering progress in understanding this deadly disease. Future work will prove crucial to determine the main contributor to CS‐B pathogenesis and identify new interactions between CS‐B‐affected mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ABC-RI, Algarve Biomedical Center Research Institute, Faro, Portugal.
- Faculdade de Medicina e Ciências Biomédicas, Universidade do Algarve, Faro, Portugal.
- Horae Gene Therapy Center, UMass Chan Medical School, Worcester, Massachusetts, USA.
- Programa doutoral em Ciências Biomédicas, Universidade do Algarve, Faro, Portugal.
- ABC Collaborative Laboratory: Integrated Ageing and Rejuvenation Solutions (ABC CoLAB-Ageing Better), Loulé, Portugal.
ORCID-Profile: David V C Brito, Clévio Nóbrega
Zitieren
APA
Afonso-Reis, R., Madeira, C. R., Brito, D. V. C., & Nóbrega, C. (2025). Insights Into Cockayne Syndrome Type B: What Underlies Its Pathogenesis?. Aging Cell. https://doi.org/10.1111/acel.70136
Vancouver
Afonso-Reis R, Madeira CR, Brito DVC, Nóbrega C. Insights Into Cockayne Syndrome Type B: What Underlies Its Pathogenesis?. Aging Cell. 2025. doi:10.1111/acel.70136
BibTeX
@article{AfonsoReis2025,
author = {Afonso-Reis, Ricardo and Madeira, Cristiana R and Brito, David V C and Nóbrega, Clévio},
title = {Insights Into Cockayne Syndrome Type B: What Underlies Its Pathogenesis?},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70136}
}
EUVIMED